What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Rice Hall James & Associates, LLC increased its holding in Genpact (NYSE:G) by 445,743 shares during the first quarter.
The estimated transaction value is $18.37 million, calculated using the average closing price for the quarter
The value of the position at quarter end rose by $14.14 million, reflecting both new purchases and stock price moves. What else to know – This buy brings the fund’s stake in Genpact (NYSE:G) to 1.46% of reportable 13F AUM. – Top holdings after the filing: – NASDAQ:LGND: $56.61 million (3.2% of AUM) – NYSE:FN: $55.18 million (3.1% of AUM) – NYSE:ARLO: $52.08 million (2.9% of AUM) – NYSE:XPO: $43.64 million (2.4% of AUM) – NASDAQ:ACIW: $41.15 million (2.3% of AUM) – – As of May 14, 2026, shares of Genpact were priced at $28.94, down 31.9% over the past year, underperforming the S&P 500 by 59.2 percentage points. Company overview Company snapshot – Genpact offers business process outsourcing, IT services, CFO advisory, ESG consulting, finance and accounting, supply chain, procurement, and digital transformation solutions. – It provides operational, technology, and consulting services to global enterprises across multiple industries. – The company serves clients in banking, capital markets, insurance, consumer goods, retail, life sciences, healthcare, high tech, manufacturing, and services sectors worldwide.
Genpact is a global provider of business process outsourcing and IT services, operating at scale with over 145,000 employees. The company leverages deep process expertise and digital capabilities to deliver cost savings, operational efficiency, and transformation for large enterprises. Its diversified client base and broad service offering support a resilient business model positioned for continued relevance in technology-enabled business solutions.